NCT06515938View on ClinicalTrials.gov

Study on New Strategies for Hepatitis B Virus Immunization

NACompletedINTERVENTIONAL
Enrollment

1,169

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2015

Conditions
Vaccine Reaction
Interventions
BIOLOGICAL

20μg Engerix-B hepatitis B vaccine

BIOLOGICAL

20μg Kangtai hepatitis B vaccine

BIOLOGICAL

60μg Kangtai hepatitis B vaccine

BIOLOGICAL

20μg CHO

Trial Locations (2)

235000

Huaibei District Center for Disease Control and Prevention, Huaibei

075199

Xuanhua District Center for Disease Control and Prevention, Xuanhua

All Listed Sponsors
lead

Wu Jiang

OTHER_GOV

NCT06515938 - Study on New Strategies for Hepatitis B Virus Immunization | Biotech Hunter | Biotech Hunter